Science Vs Science Vs

Ibogaine: A Miracle Psychedelic?

May 21, 2026

Summary

Science Vs investigates Ibogaine, a psychedelic drug gaining attention for treating opioid addiction and PTSD. Hosts Wendy Zuckerman and Meryl Horn interview users who report profound relief from cravings, alongside experts discussing the drug’s potential to promote neuroplasticity. However, the episode highlights significant risks, including fatal heart arrhythmias, and notes that rigorous clinical trials have shown mixed results compared to placebos. Ultimately, the hosts advise caution, suggesting safer, regulated alternatives like psilocybin therapy over unproven Ibogaine clinics.

Topics discussed

Intro: Ibogaine hype, Rhett's opioid addiction story, and the intense trip experience What is Ibogaine? Origins, traditional use, and brain mechanisms Research on opioid addiction: Alan Davis's study and Rhett's recovery Holly's story, neurogenesis, and how Ibogaine rewires the brain Long-term efficacy, relapse rates, and the role of maintenance doses Limitations of current research and lack of placebo-controlled trials Safety risks: Heart arrhythmias, deaths, and failed noribogaine trials Reckless dosing in studies and the combination with DMT Expert advice: Risks vs. benefits and safer alternatives like psilocybin Outro: Listener Q&A, citations, and credits

More from Science Vs

How Hard Is It to Get Off Antidepressants?
Nov 19, 2026
Is the ‘War on Science’ Over?
Nov 12, 2026
How Music Can Be Medicine, with Dr. Dan Levitin
Nov 5, 2026
Sitting: As Bad As Smoking?!
Oct 29, 2026
Testosterone: Do We All Need a Boost?
Oct 22, 2026
Listen ad-free on Castria